Intronix Technologies Corp.

Intronix Technologies Corp. specializes in intramuscular injection site nerve-locating and electromyography systems. These devices are designed to help healthcare professionals locate nerves and muscle tissue accurately during procedures like injections, reducing the risk of complications such as nerve damage or improper needle placement.

Intronix Technologies Corp. is based in the United States. The company’s location influences its regulatory compliance, as its devices must adhere to US medical device regulations, including those set by the FDA.

Intronix Technologies Corp.’s devices are classified as Class II under US regulations. This classification applies to devices that pose moderate risk and require special controls to ensure their safety and effectiveness, such as nerve-locating systems that assist in precise needle placement.

Intronix Technologies Corp.’s devices are listed in the FDA’s 510(k) and Unique Device Identification (UDI) registries. The 510(k) process demonstrates that a device is substantially equivalent to a legally marketed predicate device, while UDI ensures traceability and identification of medical devices throughout their lifecycle.